monoclonal antibodies Flashcards

1
Q

Palivizumab

A

RSV fusion protein —- only prophylaxis

premature high risk infants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

infliximab
adalimumab
certolizumab
golimumab

A

TNF alpha inhibitor

must do TB test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

TB test must be done for

A

TNF alpha inhibitors and etanercept (decoy rec)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

natalizumab

A

alpha 4 integrin —- multiple sclerosis

increase risk for PML by jc virus (polyoma DNA )

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Eculizumab

A

C5 complement protein (PNH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ustekinumab

A

IL 12 IL 23 —- psoriasis/ psoriatic arthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

alemtuzumab

A

CD52 (CLL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Muromonab

A

CD3 — T cell marker — when you dont want a t cell response like in transplants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

bevacizumab / ranibizumab

A

anti VGEF —- diabetic retinopathy

bevacizumab — colon cancer
NSLC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Omalizumab

A

igE asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

baciliximab

daclizumab

A

IL2R

CD25

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Ocrelizumab

Rituximab

A

CD 20
ocre —- MS
ritux—- non hodgkin lymphoma CD20

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

abciximab

A

gpIIb III —- prevents platelet agg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Denosumab

A

RANK L —- osteoporosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

atezolizumab
avelumab
darvalumab

A

programmed death ligand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

pembrolizumab

nevolumab

A

programmed death receptor

17
Q

ipilimumab

A

CTLA4

18
Q

tocilizumab

A

IL6

19
Q

idarucizumab

A

dabigatran reversal

20
Q

alirocumab

evolocumab

A

PCSK 9 inhibitor— degrades LDL rec